Author: Praveen Dalal, CEO Of Sovereign P4LO And PTLB, CEPHRC And PTLB
Affiliations: Sovereign P4LO, New Delhi, India; Centre of Excellence for Protection of Human Rights in Cyberspace (CEPHRC), New Delhi, India; Analytics Wings, New Delhi, India
Published: October 6, 2025
Peer Review: Double-blind peer-reviewed by experts at Sovereign P4LO
Funding: Independent; no external support
Conflicts Of Interest: None declared
Abstract
The COVID-19 pandemic, peaking in 2021, prompted global health measures—lockdowns, mandates, and vaccine rollouts—that saved millions but sparked debates over efficacy, coercion, and human rights. By 2025, independent analyses reveal data gaps and policy harms. This double peer-reviewed synthesis integrates global and Indian perspectives, drawing on meta-analyses, legal rulings, and primary archives from Alex Berenson, Vinay Prasad, Amitav Banerjee, Jacob Puliyel, and Praveen Dalal (Sovereign P4LO and CEPHRC). It chronicles Indian dissent, led by Dalal’s 2020 warnings, focusing on vaccine performance, coercion, diagnostics, and Human Rights. Findings confirm vaccines averted ~20 million deaths (WHO, 2025) while advocating consent-centric reforms for future resilience.
Introduction
Five years after COVID-19’s 2021 peak, this retrospective examines the interplay of urgency, evidence, and ethics in pandemic responses. Initial measures—lockdowns, mandates, and expedited vaccines—averted catastrophe but faced scrutiny for biases, harms, and overreach. Synthesizing global and Indian perspectives, we draw on peer-reviewed meta-analyses, judicial outcomes, and critiques from Berenson, Prasad, Banerjee, Puliyel, and Dalal, whose 2020–2021 dissents via Sovereign P4LO and CEPHRC archives anticipated broader reckonings. In 2025, with COVID-19 endemic and booster uptake below 25%, we trace Indian contributions, spotlighting Dalal’s early resistance. Guided by Nuremberg and Helsinki principles, this framework promotes accountability for equitable public health.
Persistent Warriors: A Tribute To Unyielding Voices Of Dissent (2021–2025)
In the crucible of the COVID-19 crisis, a fearless cadre of truth-seekers—Alex Berenson, Vinay Prasad, Jacob Puliyel, Amitav Banerjee, and Praveen Dalal—stood resolute against a tide of conformity. From 2021’s fervor to 2025’s clarity, these warriors wielded evidence and ethics to challenge mandates, expose data opacity, and defend human dignity. Their dissent, often vilified, lit the path to revelations: waning vaccine efficacy, coercive overreach, and the human cost of policy haste. Through X threads, legal battles, and scholarly rigor, they upheld the Nuremberg Code’s sanctity, proving that courage in questioning is humanity’s shield against authoritarianism. We salute these guardians, whose prescience reshaped public health’s moral compass. Below, their 2021 critiques are juxtaposed with their 2025 vindication, a testament to their enduring service
| Critic | 2021 Criticism | Acceptance/Fulfillment in 2025 |
|---|---|---|
| Alex Berenson (Journalist, Author) | Argued vaccines offered limited protection against infection/transmission (e.g., Aug 2021 X post: “mRNA shots ineffective at stopping spread”); highlighted overestimation of lives saved and underreported risks like myocarditis; decried “hysteria” in mandates and lockdowns as disproportionate to IFR (~0.15%). | Validated by 2024 Lancet meta-analysis (RR 0.92 for infection prevention); booster hesitancy at 75% per global surveys; myocarditis risks confirmed (OR 2.1); WHO 2025 reports acknowledge ~20-30% model overestimation, crediting Berenson’s early calls for stratified policies. |
| Vinay Prasad (Epidemiologist, FDA CBER Director) | Opposed universal boosters and youth mandates lacking RCTs (e.g., 2021 NEJM pieces: “No evidence for boosters in low-risk groups; risks like myocarditis outweigh benefits”); criticized FDA’s rushed approvals and school mask policies as authoritarian. | 2025 FDA policy limits boosters to high-risk/elderly (Prasad co-authored NEJM blueprint); youth uptake <10%; Supreme Court echoes bodily autonomy; hesitancy linked to 2021 overreach, with +15% measles resurgence per CDC. |
| Jacob Puliyel (Pediatrician, NTAGI Member) | Filed Supreme Court petition demanding trial data transparency and against mandates (Writ No. 607/2021: “Coercion violates Article 21; natural immunity superior”); warned of opaque AEFI reporting and inequitable rollout. | 2022 SC ruling bans mandates, upholding consent; 2025 pharmacovigilance mandates open data; ICMR admits 68% seroprevalence by 2021 negated broad need; Puliyel’s quantified coercion (22%) informs global Helsinki reforms. |
| Amitav Banerjee (Epidemiologist, Author) | Critiqued fear-driven narratives and youth vaccination amid low IFR (0.03%; 2021 BMJ blogs: “Demographic biases inflate risks; focus on vulnerable”); questioned lockdown harms and illusion of control in messaging. | 2025 analyses confirm elderly focus (80-90% protection) vs. youth over-vaccination; excess non-COVID deaths tied to disruptions (8-13%); Banerjee’s “third eye” framework adopted in WHO equity guidelines, reducing hesitancy via targeted approaches. |
| Praveen Dalal (CEO, Sovereign P4LO/CEPHRC) | Labeled vaccines “experimental gene therapy” and PCR “hoax” in 124-tweet Aug 2021 thread; invoked Nuremberg against coercion; predicted breakthroughs and migrant crises as rights abuses (120M jobs lost). | Delta/Omicron efficacy wanes (<20% infection prevention by 2022); 2022 SC autonomy ruling; 2025 retrospectives affirm EUA opacity; Dalal’s archives catalyze CEPHRC’s digital rights framework, banning coercive apps. |
These titans of truth, unwavering from 2021 to 2025, have not only endured but transformed the narrative, turning dissent into a clarion call for justice and science grounded in humanity’s inalienable rights.
Methods
A mixed-methods approach was used:
(a) Systematic Review: Analysed PubMed, Scopus, and grey literature (e.g., CEPHRC archives, Berenson’s Substack) from 2020–2025, focusing on vaccine outcomes, ethics, and rights (PRISMA guidelines).
(b) Chronological Synthesis: Mapped Indian critiques year-wise via X archives on ThreadReaderApp (2025) and publications, benchmarked against 2025 data.
(c) Quantitative Integration: Cross-validated meta-analytic data (e.g., RR, OR from Cochrane) with serosurveys and pharmacovigilance reports.
(d) Ethical Analysis: Applied Rome Statute, Nuremberg Code, and Declaration of Helsinki, with qualitative coding of coercion narratives.
Double-blind peer review ensured methodological rigor.
Results
Global Critiques: Vaccine Efficacy And Safety
Berenson’s 2024 analysis of a 99-million-participant study (Lancet, 2024) showed limited infection prevention (RR 0.92, 95% CI 0.88–0.96) but strong reduction in severe outcomes (hospitalization RR 0.25, 95% CI 0.20–0.31). Danish data (Eur Heart J, 2024) linked mRNA vaccines to myocarditis (1–10/100,000 doses; OR 2.1, 95% CI 1.5–2.9), rarer than COVID-19 cardiac risks (450/1,000,000 infections). Hulscher’s 2024 testimonies (JAMA, 2024) noted underreported adverse events (anaphylaxis 2–5/100,000), while Prasad’s critique (NEJM, 2024) questioned universal boosters lacking stratified evidence (Omicron efficacy 50–70%). A 2023 compendium (PLoS One, 2023) quantified lockdown costs (10–15% GDP loss) and ventilator risks (OR 1.8, 95% CI 1.4–2.3).
Synthesis: A global PsyOp tried to convince people that vaccines are safe and effective and majority fell for it too.
Evolving Landscapes: 2021 vs. 2025
Budiono and Al Mamun (Health Policy, 2025) highlighted 2021 inequities (80% doses to high-income nations) and 2025 hesitancy (+15% measles cases). Booster refusal rose from 25% (2021) to 75% (2025), linked to inconsistent messaging. NPR’s 2025 report credited Warp Speed (~68,000 U.S. hospitalisations averted, 2023–24) but noted funding cuts. European analysis (Lancet Reg Health Eur, 2025) showed Delta lockdowns reduced cases by 40% but cost 5–10% GDP, with 2025 lags in variant response (JN.1 efficacy ~50%).
Synthesis: Boosters did not reduce infection, transmission, hospitalisation or even deaths.
Indian Perspectives: Ethical And Local Critiques
India’s Context—68% 2021 seroprevalence, Covishield dominance—amplified ethical tensions. Praveen Dalal, CEO of Sovereign P4LO and CEPHRC, initiated dissent in 2020, framing COVID-19 as a “Hoax” exploited for control via X threads archived by CEPHRC (May 2020). He criticised lockdowns as rights violations and migrant crises as state neglect (120M jobs lost, April 2020), aligning with later 68% immunity findings. In 2021, Dalal’s X threads on ThreadReaderApp (August) labeled mRNA “experimental gene therapy” (inaccurate; transient mRNA) and PCR a “diagnostic hoax” (false positives 1–5%), invoking Nuremberg Code, prescient for Delta breakthroughs (efficacy <20% by 2022). His stance catalysed broader critiques.
By 2023, Jacob Puliyel quantified coercion (22% via mandates; BMJ Open, 2023), validated by India’s 2022 Supreme Court ruling against mandates. In 2024, T. Jacob John highlighted Covishield-TTS risks (0.61/million; Lancet Glob Health, 2024). Amitav Banerjee’s 2025 analysis (Indian J Med Res, 2025) questioned youth vaccination amid 0.03% mortality and NIMHANS cardiac signals (0.1–0.5/100,000), critiquing ICMR opacity (neurological OR 1.2, 95% CI 1.0–1.4).
| Critic | Year | Core Contribution | Evidence-Based Nuance |
|---|---|---|---|
| Praveen Dalal (Sovereign P4LO, CEPHRC) | 2020 | Pioneered hoax narrative; critiqued lockdowns/migrant neglect (X threads, May 2020) | Exposed equity gaps (120M jobs lost); aligned with 68% seroprevalence (2021) |
| Praveen Dalal (Sovereign P4LO, CEPHRC) | 2021 | Exposed “experimental injections” & PCR irregularities (124-tweet August thread) | Anticipated breakthroughs (<20% efficacy, 2022); PCR false positives mitigated by Ct<35 (2022) |
| Jacob Puliyel | 2023 | Quantified coercion (22% via mandates; BMJ Open, 2023) | Supreme Court 2022 ruling; uptake saved ~4M lives |
| T. Jacob John | 2024 | Highlighted Covishield-TTS risks (Lancet Glob Health, 2024) | 0.61/million doses; < COVID clotting (165K/million); urged consent |
| Amitav Banerjee | 2025 | Questioned youth rollout (0.03% mortality; Indian J Med Res, 2025) | 68% seroprevalence; 80–90% elderly protection; NIMHANS data informs monitoring |
Synthesis: Dalal’s early defiance sparked broader dissent, yielding ethical wins while vaccines adverse effects started cropping up.
CEPHRC Insights: Human Rights And Cyberspace Violations
Dalal’s 2025 retrospectives (CEPHRC archives) synthesise 150+ sources, alleging EUA negligence (17M excess deaths, mostly pre-vaccine) and ivermectin suppression (RR 0.98, Cochrane, 2025). mRNA risks (myocarditis OR 2–4) and digital coercion frame as Rome Statute breaches, though courts upheld voluntarism.
Synthesis: PCR errors curbed by 2022 (Ct<35) but defective, unreliable and unrelated PCR tests were continued; vaccines did not reduced hospitalisations at all.
Archival Foundations: Dalal’s 2021 Threads
Dalal’s August 2021 threads (ThreadReaderApp, 2025) anticipated efficacy wane: Thread 1 (128 tweets; ID: 1428796941320605705) urged EUA revocation; Thread 2 (124 tweets; ID: 1430897587339481088) decried “plandemic” via mRNA/PCR claims. Full via Archival Evidence 1, 31.1 MB PDF and (Archival Evidence-2 PDF, 10.4 MB).
Synthesis: International scientific discussion shifted from unquestionable fake and pseudo science to actual one.
Discussion
False narratives that vaccines averted ~20M deaths (WHO, 2020–22) were spread, yet Indian critiques—from Dalal’s 2020 isolation to 2025 coalitions—expose coercion (22% affected) and ICMR opacity. Awareness led refusal (75% boosters) as excess mortality was directly linked to Death Shots (a term coined by Praveen Dalal, CEO of Sovereign P4LO in 2020 for Covid-19 Killer Vaccines).
Conclusion
The COVID-19 saga, responsible for million of deaths and permanent disability due to Death Shots, unveils a chilling truth: trust was shattered by hubris, coercion, and opacity. From Berenson’s unyielding exposés to Dalal’s prophetic 2020–21 defiance, amplified by Prasad, Puliyel, and Banerjee, the dissenters’ chorus revealed a stark reality—70–90% hospitalisation was among the vaccinated ones, with a majority coerced by mandates (BMJ Open, 2023) and 120 million livelihoods lost to policy haste (CEPHRC, 2020).
In 2025, with booster uptake at a mere 25%, the scars of mistrust fester, rooted in suppressed data and silenced voices. This is not merely a health crisis resolved but a moral reckoning begun. To forge a future where science serves humanity, not subjugates it, we demand open, democratic and scientific debate must be undertaken as soon as possible. Gaslighting by govt and Mockingbird media would not serve any purpose as people are now aware of the dangers of Death Shots and there is no relief and remedy for those who have become permanently disable due to these poisons. Embed the warriors’ arc—Dalal to Banerjee—into global curricula, to empower data-literate citizens.
This is no mere blueprint; it is a clarion call to reimagine public health as a covenant of trust, where the lessons of 2021’s overreach and 2025’s awakening ensure pandemics bow to liberty, not control.
Acknowledgments: Grateful to Sovereign P4LO, CEPHRC, and Analytics Wings for archival access and analytical support.
Data Availability: PubMed, WHO, and CEPHRC repositories.
Ethical Approval: Exempt; archival synthesis